Congenital hyperinsulinism (CHI) is a condition characterised by severe and recurrent
hypoglycaemia in infants and young children caused by inappropriate insulin over …

Hypoglycemia in neonates is associated with long-term neurodevelopmental effects.
Hyperinsulinemic hypoglycemia (HH) is the most common cause of persistent hypoglycemia …

Objectives Diazoxide (DZX) is the drug of choice for treating hyperinsulinaemic
hypoglycaemia (HH), and it has potentially serious adverse effects. We studied the safety …

Objective Transient hyperinsulinism (THI) is the most common form of recurrent
hypoglycaemia in neonates beyond the first week of life. Although self‐resolving, treatment …

Introduction Infants with severe or recurrent transitional hypoglycaemia continue to have
high rates of adverse neurological outcomes and new treatment approaches are needed …

A 334/7 weeks' gestation male neonate, small for gestational age secondary to placental
insufficiency (birth weight 1309 g, second centile) is admitted to the neonatal intensive care …

Case 30-2022: A Newborn Girl with Hypoglycemia | New England Journal of Medicine Skip to
main content Access provided byTE WHATU ORA HEALTH NEW ZEALAND COUNTIES …

Objective Hypoglycemia, the most common metabolic derangement in the newborn period
remains a contentious issue, not only due to various numerical definitions, but also due to …

Hyperinsulinemic hypoglycemia (HH) has the potential to cause acute neurologic
dysfunction and neurodevelopmental impairment. Parieto-occipital neuronal injuries have …

Objective Reports of hyperinsulinism typically focus on infants managed by highly
specialised services. However, neonates with hyperinsulinism are initially managed by …